The technology of tomorrow …

The fastest gateway to a successful launch is by choosing the right lead compound early. N2MO’s ex vivo models can provide guidance to you in your early drug discovery choices!

Contact us

N2MO A/S
Islandsbrygge 79C, 8502
DK-2300 København S
Denmark

Phone: +45 3134 4896

Patents

Notice of Allowance in USA for new ex vivo model patent rights

We are hereby pleased to report that the above referenced patent application has received a Notice of Allowance, indicating that the claims presently on file are allowable.

Our unique ex vivo model described in the USA application “Methods employing insect models for determining intestinal absorption of chemical compounds” is a valuable tool to determinate the profiling of […]

By |August 4th, 2015|Patents|

N2MO is now offering unique ex vivo models for early drug discovery

N2MO is now established in offices north of Copenhagen in the DTU SCION science park in Lyngby.

N2MO is based on 8 unique patents covering ex vivo models for early drug discovery. Through close corporation with academia and the pharmaceutical environment, we have developed Grasshopper ex vivo models enabling measurement on the absorption profile of compounds […]

By |February 24th, 2015|Patents|

N2MO has been granted European (EPO) Patent

N2MO has been granted European (EPO) Patent for Screening Methods employing insects with Blood Brain Barrier
The patent covers insect models that are aimed to reflect vertebrate blood-brain barrier (BBB) penetration.

The value of the insect BBB model is that it can be just as predictive as expensive and time consuming animal models, and by using the […]

By |May 28th, 2009|About N2MO, Patents|